rs753400665
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001378609.3(OTOGL):āc.937G>Cā(p.Ala313Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000627 in 1,596,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.937G>C | p.Ala313Pro | missense_variant | 10/59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.937G>C | p.Ala313Pro | missense_variant | 10/59 | 5 | NM_001378609.3 | ENSP00000447211 | P1 | |
OTOGL | ENST00000646859.1 | c.937G>C | p.Ala313Pro | missense_variant | 15/63 | ENSP00000496036 | ||||
OTOGL | ENST00000643417.1 | n.1597G>C | non_coding_transcript_exon_variant | 13/23 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000434 AC: 1AN: 230666Hom.: 0 AF XY: 0.00000793 AC XY: 1AN XY: 126060
GnomAD4 exome AF: 0.00000623 AC: 9AN: 1443914Hom.: 0 Cov.: 32 AF XY: 0.00000418 AC XY: 3AN XY: 718496
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74326
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | May 19, 2015 | The p.Ala304Pro variant in OTOGL has not been previously reported in individuals with hearing loss or in large population studies. Computational prediction tool s and conservation analysis suggest that the p.Ala304Pro variant may not impact the protein, though this information is not predictive enough to rule out pathog enicity. In summary, the clinical significance of the p.Ala304Pro variant is unc ertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at